Overview
Amynas is a medical device company whose lead candidate is a bioresorbable pouch of electrospun nanofibers designed to promote healthy tissue growth around implants and counteract infections. The product is described as soft, easy to use, requiring no preparation, and designed to prevent hospital-acquired infections.
Key people
In the news
- Another key milestone for Amynas. Our latest results support the long-term stability of the Amynas Antibacterial Pouch, strengthening the case for a scalable, commercially viable solution targeting two of the most persistent challenges in implantable medical devices at the same time: infection risk and scar tissue formation. ❗ Why is this important? - Every 30 minutes an implant patient dies from hospital superbugs. - Current treatments often fail because they are not delivered locally to the implant and they are not time
- Big step for us at Amynas! 🚀 We've received a positive international search report from the EPO for our technology - a really nice validation that what we're building is novel and differentiated. For us, this is more than a technical step - it reinforces the strength of our IP position, which is key as we move towards global patent protection and commercialization. Proud of the team and everyone involved 👏 Full release: https://lnkd.in/ei5vJyXM #biotech #innovation #medtech #startups #intellectualproperty Lode Debrabandere
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.